"Post-TIPS HE [hepatic encephalopathy] may reflect the patients' overall vulnerability leading to an increased risk for complications and thus explaining the overall poorer prognosis of these patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Fewer patients treated with rifaximin had an overt ...

“RFX [rifaximin] therapy is effective and well-tolerated in preventing HE and can be used as the first choice in the prophylaxis of HE after TIPSS,” the authors wrote. This study was led by Yangyang ...

Dr. Derek van Amerongen introduces a panel discussing hepatic encephalopathy (HE), noting that 30-40% of cirrhotic patients develop overt HE. Dr. Arun Jesudian explains that hepatic encephalopathy (HE ...

Please provide your email address to receive an email when new articles are posted on . Patients who received oral and enema placebo experienced the highest recurrence of hepatic encephalopathy.

The performance of neurodegenerative biomarkers-neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), tau, and ubiquitin carboxy-terminal hydrolase L1 (UCHL1)-in diagnosing minimal ...

Methods In this randomized, double-blind, placebo-controlled trial, we randomly assigned 299 patients who were in remission from recurrent hepatic encephalopathy resulting from chronic liver disease ...

Research lays the groundwork for an app that may one day be able to listen to the patient read a paragraph and detect hepatic encephalopathy from their speech. Research from the University of Michigan ...